Ref.: BL-RE-092415Manufacturer ref.: EHTGFB2X10 10 x 96 tests
€4,815.00 excl. VAT
Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF...
Accession number
P61812
Dose range
8.23 to 6.000 pg/ml
Sensitivity of the dosage
15 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF...
Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF beta 3 are synthesized as very similar precursor proteins in that each is cleaved to produce a polypeptide of 112 amino acids that remains associated with the latent part of the molecule. Polypeptides of TGF beta are multifunctional; capable of influencing proliferation, differentiation and other cellular functions across a wide range of cell types. Processed tissues, as well as non-neoplastic tissues, release transformant growth factors; almost all mammalian cells have a specific TGF receptor. The multimodal nature of TGF beta is considered in its ability to stimulate or inhibit cell proliferation. In general, cells of mesenchymatous origin appear to be stimulated by beta TGF while cells of epithelial or neuroectodermal origin are inhibited by the peptide. TGF beta 1, TGF beta 2 and TGF beta 1.2 appear to be equivalent in terms of biological activity, although there appears to be differences in binding with certain receptor types. TGF beta 2 is produced by many cell types and has been found to be the highest concentration in porcine platelets and mammalian bones. The latent beta 2 TGF is the dominant isoform found in body fluids such as amniotic fluid, breast milk, and the aqueous and glassy mood of the eye.
Sensitivity
Sensitivity of dosage: 15 pg/ml.
Measurement range
Dose range: 8.23 to 6.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.